An investigation for investors in Novan Inc (NASDAQ:NOVN) shares over potential securities laws violations by Novan Inc NASDAQ:NOVN was announced and NASDAQ:NOVN stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 01/31/2017 --An investigation on behalf of investors of Novan Inc over potential securities laws violations by Novan Inc NASDAQ:NOVN and certain of its directors and officers was announced.

Investors who purchased shares of Novan Inc NASDAQ:NOVN, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on whether a series of statements by Novan Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 27, 2017, Novan Inc NASDAQ:NOVN announced top-line results from the Company's two, replicate Phase 3 pivotal clinical trials for SB204 in the treatment of acne vulgaris. Shares of Novan Inc (NASDAQ:NOVN) dropped on January 27, 2017 to as low as $3.52 per share.

Those who purchased shares of Novan Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com